You searched for "regenerative"
Predicting outcome for visual acuity in optic neuritis associated with multiple sclerosis
3 October 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective cohort study to evaluate key predictors of long-term high-contrast visual acuity following optic neuritis associated with multiple sclerosis. All patients coded as optic neuropathy and assessed by a neuro-ophthalmologist over a 10-year period were screened...
Boosting key protein in eye cells could prevent age-related vision loss, international team finds
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.CHEC treats first surgical eye patients at Stockport Exchange
Community healthcare provider restores sight for local residents in partnership with the NHS.
Bupivicaine injection for Bell’s palsy
1 April 2016
| James Hsuan
|
EYE - Neuro-ophthalmology
This study assesses the use of intramuscular bupivicaine to treat lid retraction and lagophthalmos in facial palsy. It is a prospective non-comparative interventional series of 10 patients with Bell’s palsy (House-Brackman grade IV or V) who each received three serial...
Conjunctival melanoma involving the lacrimal drainage system
A total of 52 patients were diagnosed with conjunctival melanoma over a period of 17 years, 17 of whom required orbital exenteration. Five of these were found to have melanoma involving the lacrimal drainage apparatus (LDA). One was evident clinically...Clinical relevance of the anatomic classification of neovascular age-related macular degeneration
The author explains why an OCT-based classification of neovascular AMD is needed and how these neovascular subtypes may help to predict patients’ long-term visual outcome. Age-related macular degeneration (AMD) is a chronic and progressive neurodegenerative process involving the macula in...
Features, treatment and prevention of conjunctival inclusion cysts
Conjunctival inclusion cyst is a rare complication of strabismus surgery and generally develops at the point of muscle reattachment, caused by implantation of conjunctival epithelium. The authors aimed to determine the rate of its development after strabismus surgery and consider...RNIB appoints Sir Jim Harra as new Vice Chair
The Royal National Institute of Blind People (RNIB) has appointed Sir Jim Harra to take up the roles of Vice Chair of the Board of Trustees and Chair of the Governance, Nominations and Remuneration Committee. Jim was previously a Permanent...It’s not all about ARED - Time for a pragmatic approach to nutrition for eye health?
1 April 2016
| Christine Purslow (Prof)
|
EYE - Cornea
Advances in treatment for retinal diseases involving neovascularisation have undoubtedly changed the future of eye care across the UK for the better, but also created great challenges for service delivery in ophthalmology, particularly within the NHS. Some statistics are starting...
Developments in Ophthalmology: Ophthalmic Radiation Therapy Techniques and Applications
1 February 2015
| Sofia Rokerya
|
EYE - Paediatrics, EYE - Strabismus, EYE - General, EYE - Neuro-ophthalmology
Radiation was discovered by Wilhelm Roentgen in 1895, and since then has been used to treat a variety of cancers. Its therapeutic properties have been widely used for ocular and periocular tumours and inflammatory disease, but the present era is...
Vision loss during Eylea treatment for AMD
1 December 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
This report investigated patients who lost more than two lines of vision despite periodic injections of aflibercept and explored the factors associated with vision loss. One hundred and ninety-six eyes were included in this study over a two year period....
Outcomes of ‘treat and extend’ for neovascular AMD
1 August 2015
| Brian Ang
|
EYE - Vitreo-Retinal
The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...
